Serfibrate
- Level
- Commodity
- Parent
- 51321800
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51321813This classification denotes an anti-lipidemic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 910906N64M. European Medicines Agency schedules Serfibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10492MIG. Serfibrate generally arises in the molecular formula C16H20CLNO5S. The term SERFIBRATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16.) SERFIBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule serfibrate under HS 29309085 and SITC 51549. As of Q4 2014, SERFIBRATE remains the US FDA Preferred Term for this commodity. Serfibrate bears US NLM identifiers UMLS ID C2348187 and NCI Concept Code C72997. SMILES: Clc1ccc(OC(C(=O)SCC(NC(=O)C)CC(=O)O)(C)C)cc1.
Same parent
Under 51321800 · 17Activities that produce or sell this
KBLI · 8Inherited from family 51320000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.